{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:17:58Z","timestamp":1792801078013,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:00:00Z","timestamp":1769299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of Zhejiang Province","award":["LQ20H270014"],"award-info":[{"award-number":["LQ20H270014"]}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LY23H280010"],"award-info":[{"award-number":["LY23H280010"]}],"id":[{"id":"https:\/\/ror.org\/04aqat463","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Research Project of Zhejiang Chinese Medical University","award":["2023JKZKTS23"],"award-info":[{"award-number":["2023JKZKTS23"]}],"id":[{"id":"https:\/\/ror.org\/04epb4p87","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04071-4","type":"journal-article","created":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T06:37:18Z","timestamp":1769323038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Synergistic regulation of TGF-\u03b21\/Smad2\/3 signaling and inflammatory pathways via SA\/NAC-based nanoplatforms: a novel strategy to enhance anti-fibrotic therapeutic outcomes in idiopathic pulmonary fibrosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Ce","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeling","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigang","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,25]]},"reference":[{"key":"4071_CR1","doi-asserted-by":"publisher","unstructured":"Zheng D et al. Supramolecular nanofibers ameliorate Bleomycin-Induced pulmonary fibrosis by restoring autophagy. Adv Sci. 2024;11(28):2401327. https:\/\/doi.org\/10.1002\/advs.202401327","DOI":"10.1002\/advs.202401327"},{"key":"4071_CR2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chest.2020.07.035","volume":"159","author":"E Farrand","year":"2021","unstructured":"Farrand E, et al. Impact of Idiopathic Pulmonary Fibrosis on Longitudinal Health-care Utilization in a Community-Based Cohort of Patients. Chest. 2021;159:219\u201327.","journal-title":"Chest"},{"key":"4071_CR3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11739-019-02195-0","volume":"15","author":"S Harari","year":"2020","unstructured":"Harari S, et al. Epidemiology of idiopathic pulmonary fibrosis: a population-based study in primary care. Intern Emerg Med. 2020;15:437\u201345.","journal-title":"Intern Emerg Med"},{"key":"4071_CR4","doi-asserted-by":"crossref","DOI":"10.3390\/ph14080807","volume":"14","author":"E Bazdyrev","year":"2021","unstructured":"Bazdyrev E, et al. Lung fibrosis after COVID-19: treatment prospects. Pharmaceuticals. 2021;14:807.","journal-title":"Pharmaceuticals"},{"key":"4071_CR5","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1016\/j.cell.2021.11.033","volume":"184","author":"D Wendisch","year":"2021","unstructured":"Wendisch D, et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021;184:6243\u2013e626127.","journal-title":"Cell"},{"key":"4071_CR6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","volume":"8","author":"PM George","year":"2020","unstructured":"George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med. 2020;8:807\u201315.","journal-title":"Lancet Respir Med"},{"key":"4071_CR7","doi-asserted-by":"publisher","unstructured":"Koudstaal T, Wijsenbeek MS. Idiopathic pulmonary fibrosis. Presse Med. 2023;52(3):104166. https:\/\/doi.org\/10.1016\/j.lpm.2023.104166}","DOI":"10.1016\/j.lpm.2023.104166"},{"key":"4071_CR8","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/jmv.26634","volume":"93","author":"C Zhang","year":"2021","unstructured":"Zhang C, et al. Discharge may not be the end of treatment: pay attention to pulmonary fibrosis caused by severe COVID-19. J Med Virol. 2021;93:1378\u201386.","journal-title":"J Med Virol"},{"key":"4071_CR9","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.7150\/thno.54217","volume":"11","author":"J Hou","year":"2021","unstructured":"Hou J, et al. Co-delivery of siPTPN13 and siNOX4 via (myo)fibroblast-targeting polymeric micelles for idiopathic pulmonary fibrosis therapy. Theranostics. 2021;11:3244\u201361.","journal-title":"Theranostics"},{"key":"4071_CR10","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113979","volume":"147","author":"MP Vithalkar","year":"2025","unstructured":"Vithalkar MP, et al. Network pharmacology-driven therapeutic interventions for interstitial lung diseases using traditional medicines: a narrative review. Int Immunopharmacol. 2025;147:113979.","journal-title":"Int Immunopharmacol"},{"key":"4071_CR11","volume":"147","author":"B An","year":"2024","unstructured":"An B, et al. Inhibition of TGF-\u03b21\/Smad3 signaling by compound 5aa: a potential treatment for idiopathic pulmonary fibrosis. Bioorg Chem. 2024;147:107374.","journal-title":"Bioorg Chem"},{"key":"4071_CR12","volume":"197","author":"L Hou","year":"2023","unstructured":"Hou L, et al. 2-methoxyestradiol ameliorates paraquat-induced pulmonary fibrosis by inhibiting the TGF-\u03b21\/Smad2\/3 signaling pathway. Pestic Biochem Physiol. 2023;197:105647.","journal-title":"Pestic Biochem Physiol"},{"key":"4071_CR13","volume":"316","author":"Y Li","year":"2023","unstructured":"Li Y, et al. Bufei huoxue capsule alleviates bleomycin-induced pulmonary fibrosis in mice via TGF-\u03b21\/Smad2\/3 signaling. J Ethnopharmacol. 2023;316:116733.","journal-title":"J Ethnopharmacol"},{"key":"4071_CR14","volume":"270","author":"Z Tan","year":"2021","unstructured":"Tan Z, et al. Taohong siwu decoction attenuates myocardial fibrosis by inhibiting fibrosis proliferation and collagen deposition via TGFBR1 signaling pathway. J Ethnopharmacol. 2021;270:113838.","journal-title":"J Ethnopharmacol"},{"key":"4071_CR15","volume":"324","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. Leech extract alleviates idiopathic pulmonary fibrosis by TGF-\u03b21\/Smad3 signaling pathway. J Ethnopharmacol. 2024;324:117737.","journal-title":"J Ethnopharmacol"},{"key":"4071_CR16","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1080\/15548627.2022.2046448","volume":"18","author":"J Zhang","year":"2022","unstructured":"Zhang J, et al. ATF3 -activated accelerating effect of LINC00941\/lncIAPF on fibroblast-to-myofibroblast differentiation by blocking autophagy depending on ELAVL1\/HuR in pulmonary fibrosis. Autophagy. 2022;18:2636\u201355.","journal-title":"Autophagy"},{"key":"4071_CR17","volume":"20","author":"J Liu","year":"2022","unstructured":"Liu J, et al. ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signaling. J Nanobiotechnol. 2022;20:213.","journal-title":"J Nanobiotechnol"},{"key":"4071_CR18","volume":"8","author":"X Bai","year":"2022","unstructured":"Bai X, et al. Inhaled siRNA nanoparticles targeting IL11 inhibit lung fibrosis and improve pulmonary function post-bleomycin challenge. Sci Adv. 2022;8:eabn7162.","journal-title":"Sci Adv"},{"key":"4071_CR19","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107798","volume":"222","author":"P Spagnolo","year":"2021","unstructured":"Spagnolo P, et al. Idiopathic pulmonary fibrosis: disease mechanisms and drug development. Pharmacol Ther. 2021;222:107798.","journal-title":"Pharmacol Ther"},{"key":"4071_CR20","doi-asserted-by":"publisher","unstructured":"Amirkhosravi A et al. Losartan enhances the suppressive effect of Pirfenidone on the bleomycin-induced epithelial-mesenchymal transition and oxidative stress in A549 cell line. Iran J Basic Med Sci. 2023;26(8):972\u2013978. https:\/\/doi.org\/10.22038\/IJBMS.2023.68982.15035","DOI":"10.22038\/IJBMS.2023.68982.15035"},{"key":"4071_CR21","volume":"14","author":"A Amirkhosravi","year":"2024","unstructured":"Amirkhosravi A, et al. Combination of losartan with pirfenidone: a protective anti-fibrotic against pulmonary fibrosis induced by bleomycin in rats. Sci Rep. 2024;14:8729.","journal-title":"Sci Rep"},{"key":"4071_CR22","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv-2022-0n8fp","author":"R Miller","year":"2022","unstructured":"Miller R, et al. An approach to the proposal of drug combination for cancer therapy using a pathway data connectivity approach. Preprint at. 2022. https:\/\/doi.org\/10.26434\/chemrxiv-2022-0n8fp.","journal-title":"Preprint at"},{"key":"4071_CR23","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1002\/ptr.7253","volume":"35","author":"Z Xue","year":"2021","unstructured":"Xue Z, et al. Combination therapy of Tanshinone IIA and puerarin for pulmonary fibrosis via targeting IL6-JAK2\u2010STAT3 \/ STAT1 signaling pathways. Phytother Res. 2021;35:5883\u201398.","journal-title":"Phytother Res"},{"key":"4071_CR24","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang X, et al. Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF\/JAK1\/STAT3 and NF-kB signaling pathways synergistically. Clin Transl Med. 2021;11:e335.","journal-title":"Clin Transl Med"},{"key":"4071_CR25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000502536","volume":"104","author":"H Jiao","year":"2019","unstructured":"Jiao H, Song J, Sun X, Sun D, Zhong M. Sodium arsenite inhibits lung fibroblast differentiation and pulmonary fibrosis. Pharmacology. 2019;104:368\u201376.","journal-title":"Pharmacology"},{"key":"4071_CR26","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.115972","volume":"441","author":"A Joannes","year":"2022","unstructured":"Joannes A, et al. Arsenic trioxide inhibits the functions of lung fibroblasts derived from patients with idiopathic pulmonary fibrosis. Toxicol Appl Pharmacol. 2022;441:115972.","journal-title":"Toxicol Appl Pharmacol"},{"key":"4071_CR27","doi-asserted-by":"crossref","first-page":"1536388","DOI":"10.3389\/fphar.2025.1536388","volume":"16","author":"J Wen","year":"2025","unstructured":"Wen J, et al. Hepatotoxicity induced by arsenic trioxide: clinical features, mechanisms, preventive and potential therapeutic strategies. Front Pharmacol. 2025;16:1536388.","journal-title":"Front Pharmacol"},{"key":"4071_CR28","doi-asserted-by":"crossref","first-page":"110713","DOI":"10.1016\/j.biopha.2020.110713","volume":"131","author":"Y Liang","year":"2020","unstructured":"Liang Y, et al. Crocin ameliorates arsenic trioxide\u2013induced cardiotoxicity via Keap1-Nrf2\/HO-1 pathway: reducing oxidative stress, inflammation, and apoptosis. Biomed Pharmacother. 2020;131:110713.","journal-title":"Biomed Pharmacother"},{"key":"4071_CR29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12012-018-09504-7","volume":"19","author":"VP Vineetha","year":"2019","unstructured":"Vineetha VP, Raghu KG. An overview on arsenic trioxide-induced cardiotoxicity. Cardiovasc Toxicol. 2019;19:105\u201319.","journal-title":"Cardiovasc Toxicol"},{"key":"4071_CR30","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12091713","volume":"12","author":"D Mokra","year":"2023","unstructured":"Mokra D, Mokry J, Barosova R, Hanusrichterova J. Advances in the use of N-acetylcysteine in chronic respiratory diseases. Antioxidants. 2023;12:1713.","journal-title":"Antioxidants"},{"key":"4071_CR31","volume":"157","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, et al. S-allylmercapto-N-acetylcysteine ameliorates pulmonary fibrosis in mice via Nrf2 pathway activation and NF-\u03baB, TGF-\u03b21\/Smad2\/3 pathway suppression. Biomed Pharmacother. 2023;157:114018.","journal-title":"Biomed Pharmacother"},{"key":"4071_CR32","volume":"12","author":"H Zeng","year":"2023","unstructured":"Zeng H, et al. Current strategies for exosome cargo loading and targeting delivery. Cells. 2023;12:1416.","journal-title":"Cells"},{"key":"4071_CR33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.semcancer.2024.04.002","volume":"101","author":"EM Vaiaki","year":"2024","unstructured":"Vaiaki EM, Falasca M. Comparative analysis of the minimal information for studies of extracellular vesicles guidelines: advancements and implications for extracellular vesicle research. Semin Cancer Biol. 2024;101:12\u201324.","journal-title":"Semin Cancer Biol"},{"key":"4071_CR34","doi-asserted-by":"crossref","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicle. 2024;13:e12404.","journal-title":"J Extracell Vesicle"},{"key":"4071_CR35","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jconrel.2022.09.045","volume":"351","author":"M Zhou","year":"2022","unstructured":"Zhou M, et al. Apoptotic bodies for advanced drug delivery and therapy. J Control Release. 2022;351:394\u2013406.","journal-title":"J Control Release"},{"key":"4071_CR36","volume":"10","author":"Y Cui","year":"2023","unstructured":"Cui Y, et al. Melatonin engineering M2 macrophage-derived exosomes mediate endoplasmic reticulum stress and immune reprogramming for periodontitis therapy. Adv Sci. 2023;10:2302029.","journal-title":"Adv Sci"},{"key":"4071_CR37","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.nano.2016.12.015","volume":"13","author":"DK McDaniel","year":"2017","unstructured":"McDaniel DK, et al. TIPS pentacene loaded PEO-PDLLA core-shell nanoparticles have similar cellular uptake dynamics in M1 and M2 macrophages and in corresponding in vivo microenvironments. Nanomedicine Nanotechnol Biol Med. 2017;13:1255\u201366.","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"key":"4071_CR38","doi-asserted-by":"crossref","unstructured":"Ralph SJ. Arsenic-Based Antineoplastic Drugs and Their Mechanisms of Action. Metal-Based Drugs 2008, 1\u201313 (2008).","DOI":"10.1155\/2008\/260146"},{"key":"4071_CR39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1039\/D3BM01311A","volume":"12","author":"C Li","year":"2024","unstructured":"Li C, et al. Macrophage-hitchhiked arsenic\/AB bionic preparations for liver cancer. Biomater Sci. 2024;12:187\u201398.","journal-title":"Biomater Sci"},{"key":"4071_CR40","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.3390\/ijms22115909","volume":"22","author":"P Solopov","year":"2021","unstructured":"Solopov P, Colunga Biancatelli RML, Dimitropoulou C, Catravas JD. Sex-related differences in murine models of chemically induced pulmonary fibrosis. Int J Mol Sci. 2021;22:5909.","journal-title":"Int J Mol Sci"},{"key":"4071_CR41","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1164\/rccm.202506-1361ST","volume":"211","author":"K Lingappan","year":"2025","unstructured":"Lingappan K, et al. Addressing sex as a biological variable in preclinical models of lung disease: an official American Thoracic Society research statement. Am J Respir Crit Care Med. 2025;211:1346\u201368.","journal-title":"Am J Respir Crit Care Med"},{"key":"4071_CR42","doi-asserted-by":"crossref","DOI":"10.3352\/jeehp.2021.18.17","volume":"18","author":"H Kang","year":"2021","unstructured":"Kang H. Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof. 2021;18:17.","journal-title":"J Educ Eval Health Prof"},{"key":"4071_CR43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"T-C Chou","year":"2006","unstructured":"Chou T-C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev. 2006;58:621\u201381.","journal-title":"Pharmacol Rev"},{"key":"4071_CR44","doi-asserted-by":"crossref","first-page":"20175","DOI":"10.1038\/s41598-023-47445-6","volume":"13","author":"R Schmid","year":"2023","unstructured":"Schmid R, et al. Surface functionalization affects the retention and bio-distribution of orally administered mesoporous silica nanoparticles in a colitis mouse model. Sci Rep. 2023;13:20175.","journal-title":"Sci Rep"},{"key":"4071_CR45","doi-asserted-by":"publisher","unstructured":"Fr\u00f6hlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. IJN. 2012;5577. https:\/\/doi.org\/10.2147\/IJN.S36111.","DOI":"10.2147\/IJN.S36111"},{"key":"4071_CR46","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.25258\/ijddt.12.3.34","volume":"12","author":"B Madupoju","year":"2022","unstructured":"Madupoju B, et al. Development, characterization and optimization of N-acetylcysteine-loaded solid lipid particles: in-vitro and in-vivo study. IJDDT. 2022;12:1129\u201335.","journal-title":"IJDDT"},{"key":"4071_CR47","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3390\/app13031726","volume":"13","author":"C-H Tang","year":"2023","unstructured":"Tang C-H, Chen H-L, Dong J-R. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) as food-grade nanovehicles for hydrophobic nutraceuticals or bioactives. Appl Sci. 2023;13:1726.","journal-title":"Appl Sci"},{"key":"4071_CR48","volume":"130","author":"L Deng","year":"2024","unstructured":"Deng L, et al. Icariside II modulates pulmonary fibrosis via PI3K\/Akt\/\u03b2-catenin pathway inhibition of M2 macrophage program. Phytomedicine. 2024;130:155687.","journal-title":"Phytomedicine"},{"key":"4071_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.678457","author":"A Kishore","year":"2021","unstructured":"Kishore A, Petrek M. Roles of macrophage polarization and macrophage-derived miRNAs in pulmonary fibrosis. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.678457.","journal-title":"Front Immunol"},{"key":"4071_CR50","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1007\/s11427-022-2314-8","volume":"66","author":"L Yan","year":"2023","unstructured":"Yan L, et al. Local administration of liposomal-based Plekhf1 gene therapy attenuates pulmonary fibrosis by modulating macrophage polarization. Sci China Life Sci. 2023;66:2571\u201386.","journal-title":"Sci. China Life Sci."},{"key":"4071_CR51","volume":"203","author":"J Zhu","year":"2024","unstructured":"Zhu J, et al. IL20Rb aggravates pulmonary fibrosis through enhancing bone marrow derived profibrotic macrophage activation. Pharmacol Res. 2024;203:107178.","journal-title":"Pharmacol Res"},{"key":"4071_CR52","doi-asserted-by":"crossref","first-page":"11443","DOI":"10.3390\/ijms231911443","volume":"23","author":"E Sari","year":"2022","unstructured":"Sari E, He C, Margaroli C. Plasticity towards rigidity: a macrophage conundrum in pulmonary fibrosis. Int J Mol Sci. 2022;23:11443.","journal-title":"Int J Mol Sci"},{"key":"4071_CR53","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.7150\/thno.48152","volume":"11","author":"T Pan","year":"2021","unstructured":"Pan T, et al. Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis. Theranostics. 2021;11:1192\u2013206.","journal-title":"Theranostics"},{"key":"4071_CR54","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/s41418-020-00650-6","volume":"28","author":"L-Z Rao","year":"2021","unstructured":"Rao L-Z, et al. IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages. Cell Death Differ. 2021;28:1270\u201383.","journal-title":"Cell Death Differ"},{"key":"4071_CR55","doi-asserted-by":"publisher","unstructured":"Wang Y et al. MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program. Sci Adv. 2021;7(1):eabb6075. https:\/\/doi.org\/10.1126\/sciadv.abb6075.","DOI":"10.1126\/sciadv.abb6075"},{"key":"4071_CR56","volume":"15","author":"Z Ge","year":"2024","unstructured":"Ge Z, Chen Y, Ma L, Hu F, Xie L. Macrophage polarization and its impact on idiopathic pulmonary fibrosis. Front Immunol. 2024;15:1444964.","journal-title":"Front. Immunol"},{"key":"4071_CR57","doi-asserted-by":"publisher","unstructured":"Yue B et al. SPP1 induces idiopathic pulmonary fibrosis and NSCLC progression via the PI3K\/Akt\/mTOR pathway. Respir Res. 2024;25(1):362. https:\/\/doi.org\/10.1186\/s12931-024-02989-7","DOI":"10.1186\/s12931-024-02989-7"},{"key":"4071_CR58","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.actbio.2023.06.024","volume":"167","author":"T Zhao","year":"2023","unstructured":"Zhao T, et al. A fibroblastic foci-targeting and hypoxia-cleavable delivery system of pirfenidone for the treatment of idiopathic pulmonary fibrosis. Acta Biomater. 2023;167:574\u201382.","journal-title":"Acta Biomater"},{"key":"4071_CR59","volume":"243","author":"Y Bai","year":"2024","unstructured":"Bai Y, et al. 18\u03b2-glycyrrhetinic acid ameliorates bleomycin-induced idiopathic pulmonary fibrosis via inhibiting TGF-\u03b21\/JAK2\/STAT3 signaling axis. J Steroid Biochem Mol Biol. 2024;243:106560.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4071_CR60","volume":"81","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhang W, Zhang R, Xia Y. Knockdown of FBLN2 suppresses TGF-\u03b21-induced MRC-5 cell migration and fibrosis by downregulating VTN. Tissue Cell. 2023;81:102005.","journal-title":"Tissue Cell"},{"key":"4071_CR61","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1084\/jem.20101157","volume":"207","author":"KS Ravichandran","year":"2010","unstructured":"Ravichandran KS. Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums. J Exp Med. 2010;207:1807\u201317.","journal-title":"J Exp Med"},{"key":"4071_CR62","doi-asserted-by":"crossref","first-page":"e9130013","DOI":"10.26599\/NTM.2022.9130013","volume":"1","author":"S Wang","year":"2022","unstructured":"Wang S, et al. Recent advances in macrophage-derived exosomes as delivery vehicles. Nano TransMed. 2022;1:e9130013.","journal-title":"Nano TransMed"},{"key":"4071_CR63","doi-asserted-by":"crossref","first-page":"100082","DOI":"10.1016\/j.ntm.2025.100082","volume":"4","author":"MAJ Shaikh","year":"2025","unstructured":"Shaikh MAJ, et al. Liposome-encapsulated therapies: precision medicine for inflammatory lung disorders. Nano TransMed. 2025;4:100082.","journal-title":"Nano TransMed"},{"key":"4071_CR64","doi-asserted-by":"publisher","unstructured":"Dhar R, Subramaniyan V, Exosomes. A next-generation cancer theranostics. Nano TransMed. 2025;100096. https:\/\/doi.org\/10.1016\/j.ntm.2025.100096.","DOI":"10.1016\/j.ntm.2025.100096"},{"key":"4071_CR65","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1007\/s13346-023-01368-x","volume":"13","author":"J Qian","year":"2023","unstructured":"Qian J, et al. Combination of micelles and liposomes as a promising drug delivery system: a review. Drug Deliv and Transl Res. 2023;13:2767\u201389.","journal-title":"Drug Deliv. and Transl. Res"},{"key":"4071_CR66","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/molecules27041372","volume":"27","author":"P Liu","year":"2022","unstructured":"Liu P, Chen G, Zhang JA. Review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives. Molecules. 2022;27:1372.","journal-title":"Molecules"},{"key":"4071_CR67","volume":"31","author":"Y-F Chen","year":"2024","unstructured":"Chen Y-F, Luh F, Ho Y-S, Yen Y. Exosomes: a review of biologic function, diagnostic and targeted therapy applications, and clinical trials. J Biomed Sci. 2024;31:67.","journal-title":"J Biomed Sci"},{"key":"4071_CR68","volume":"15","author":"HB Koh","year":"2023","unstructured":"Koh HB, Kim HJ, Kang S-W, Yoo T-H. Exosome-based drug delivery: translation from bench to clinic. Pharmaceutics. 2023;15:2042.","journal-title":"Pharmaceutics"},{"key":"4071_CR69","volume":"25","author":"KWA Lee","year":"2024","unstructured":"Lee KWA, et al. Clinical applications of exosomes: a critical review. Int J Mol Sci. 2024;25:7794.","journal-title":"Int J Mol Sci"},{"key":"4071_CR70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s44258-024-00039-x","volume":"2","author":"D Han","year":"2024","unstructured":"Han D, Li Z, Wang F, Cheng K, Shen D. Apoptotic extracellular vesicles: mechanisms, applications, and therapeutic potential. Med-X. 2024;2:27.","journal-title":"Med-X"},{"key":"4071_CR71","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.132186.1","volume":"12","author":"D Ramesh","year":"2023","unstructured":"Ramesh D, Bakkannavar S, Bhat VR, Sharan K. Extracellular vesicles as novel drug delivery systems to target cancer and other diseases: recent advancements and future perspectives. F1000Res. 2023;12:329.","journal-title":"F1000Res"},{"key":"4071_CR72","volume":"21","author":"S Du","year":"2023","unstructured":"Du S, et al. Extracellular vesicles: a rising star for therapeutics and drug delivery. J Nanobiotechnology. 2023;21:231.","journal-title":"J Nanobiotechnology"},{"key":"4071_CR73","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1002\/mco2.744","volume":"5","author":"J Wang","year":"2024","unstructured":"Wang J, et al. Pulmonary fibrosis: pathogenesis and therapeutic strategies. MedComm. 2024;5:e744.","journal-title":"MedComm"},{"key":"4071_CR74","volume":"16","author":"J Bhatt","year":"2025","unstructured":"Bhatt J, Ghigo A, Hirsch E. PI3K\/Akt in IPF: untangling fibrosis and charting therapies. Front Immunol. 2025;16:1549277.","journal-title":"Front Immunol"},{"key":"4071_CR75","volume":"55","author":"P Kolb","year":"2020","unstructured":"Kolb P, et al. The importance of interventional timing in the bleomycin model of pulmonary fibrosis. Eur Respir J. 2020;55:1901105.","journal-title":"Eur Respir J"},{"key":"4071_CR76","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1021\/acsnano.4c09525","volume":"19","author":"M-R Chiang","year":"2025","unstructured":"Chiang M-R, et al. Reprogramming dysfunctional dendritic cells by a versatile catalytic dual oxide antigen-captured nanosponge for remotely enhancing lung metastasis immunotherapy. ACS Nano. 2025;19:2117\u201335.","journal-title":"ACS Nano"},{"key":"4071_CR77","doi-asserted-by":"crossref","first-page":"25134","DOI":"10.1021\/acsnano.5c05395","volume":"19","author":"TMH Huynh","year":"2025","unstructured":"Huynh TMH, et al. Reprogramming immunodeficiency in lung metastases via PD-L1 siRNA delivery and antigen capture of nanosponge-mediated dendritic cell modulation. ACS Nano. 2025;19:25134\u201353.","journal-title":"ACS Nano"},{"key":"4071_CR78","doi-asserted-by":"crossref","first-page":"18712","DOI":"10.1021\/acsnano.4c06183","volume":"18","author":"BN Yalamandala","year":"2024","unstructured":"Yalamandala BN, et al. A self-cascade penetrating brain tumor immunotherapy mediated by near-infrared II cell membrane-disrupting nanoflakes via detained dendritic cells. ACS Nano. 2024;18:18712\u201328.","journal-title":"ACS Nano"},{"key":"4071_CR79","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102838","volume":"65","author":"T Moorthy","year":"2025","unstructured":"Moorthy T, et al. Wireless chargeable gold yarnball-mediated mitochondrial depolarization for dendritic cell detainment in programmed brain tumor immunotherapy. Nano Today. 2025;65:102838.","journal-title":"Nano Today"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04071-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04071-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04071-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T14:28:52Z","timestamp":1771338532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04071-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,25]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4071"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04071-4","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,25]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"173"}}